- call +1-201-465-4211
- email sales@mrinsights.biz
A "humanized" immune system rodent model is one in which human primary haematopoietic cells and tissues are implanted into an immunodeficient host that generate a functional human immune system. Humanized mice or rat model are commonly used as small animal models in biological and medical research for human therapeutics.
Scope of the Report:
Growth in this market can primarily be attributed to factors such as the growing demand of personalized medicine, continuous support in the form of investments and grants from the government and private sectors, increasing number of R&D activities in pharmaceutical and biotechnology companies, and the increasing number of research activities involving humanized models. Increasing production of monoclonal antibodies and rising demand for humanized rat models are expected to provide a wide range of growth opportunities for players in the market.
The worldwide market for Humanized Mouse and Rat Model is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Humanized Mouse and Rat Model in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
The Jackson Laboratory (US)
Taconic Biosciences (US)
Horizon Discovery Group plc (UK)
genOway (France)
Charles River Laboratories (US)
Harbour Antibodies BV (China)
Hera BioLabs (US)
Vitalstar Biotechnology Co (China)
inGenious Targeting Laboratory (US)
AXENIS S.A.S (France)
Crown Bioscience (US)
Transgenic (Japan)
Champions Oncology (US)
Horizon Discovery Group plc (UK)
Hera BioLabs (US)
Yecuris Corporation (US)
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Genetic
Cell-Based
Market Segment by Applications, can be divided into
Pharmaceutical
Biotechnology Companies
CRO
There are 15 Chapters to deeply display the global Humanized Mouse and Rat Model market.
Chapter 1, to describe Humanized Mouse and Rat Model Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Humanized Mouse and Rat Model, with sales, revenue, and price of Humanized Mouse and Rat Model, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Humanized Mouse and Rat Model, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Humanized Mouse and Rat Model market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Humanized Mouse and Rat Model sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Humanized Mouse and Rat Model Introduction
1.2 Market Analysis by Type
1.2.1 Genetic
1.2.2 Cell-Based
1.3 Market Analysis by Applications
1.3.1 Pharmaceutical
1.3.2 Biotechnology Companies
1.3.3 CRO
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 The Jackson Laboratory (US)
2.1.1 Business Overview
2.1.2 Humanized Mouse and Rat Model Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 The Jackson Laboratory (US) Humanized Mouse and Rat Model Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Taconic Biosciences (US)
2.2.1 Business Overview
2.2.2 Humanized Mouse and Rat Model Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Taconic Biosciences (US) Humanized Mouse and Rat Model Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Horizon Discovery Group plc (UK)
2.3.1 Business Overview
2.3.2 Humanized Mouse and Rat Model Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Horizon Discovery Group plc (UK) Humanized Mouse and Rat Model Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 genOway (France)
2.4.1 Business Overview
2.4.2 Humanized Mouse and Rat Model Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 genOway (France) Humanized Mouse and Rat Model Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Charles River Laboratories (US)
2.5.1 Business Overview
2.5.2 Humanized Mouse and Rat Model Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Charles River Laboratories (US) Humanized Mouse and Rat Model Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Harbour Antibodies BV (China)
2.6.1 Business Overview
2.6.2 Humanized Mouse and Rat Model Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Harbour Antibodies BV (China) Humanized Mouse and Rat Model Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Hera BioLabs (US)
2.7.1 Business Overview
2.7.2 Humanized Mouse and Rat Model Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Hera BioLabs (US) Humanized Mouse and Rat Model Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Vitalstar Biotechnology Co (China)
2.8.1 Business Overview
2.8.2 Humanized Mouse and Rat Model Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Vitalstar Biotechnology Co (China) Humanized Mouse and Rat Model Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 inGenious Targeting Laboratory (US)
2.9.1 Business Overview
2.9.2 Humanized Mouse and Rat Model Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 inGenious Targeting Laboratory (US) Humanized Mouse and Rat Model Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 AXENIS S.A.S (France)
2.10.1 Business Overview
2.10.2 Humanized Mouse and Rat Model Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 AXENIS S.A.S (France) Humanized Mouse and Rat Model Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Crown Bioscience (US)
2.11.1 Business Overview
2.11.2 Humanized Mouse and Rat Model Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Crown Bioscience (US) Humanized Mouse and Rat Model Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Transgenic (Japan)
2.12.1 Business Overview
2.12.2 Humanized Mouse and Rat Model Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Transgenic (Japan) Humanized Mouse and Rat Model Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Champions Oncology (US)
2.13.1 Business Overview
2.13.2 Humanized Mouse and Rat Model Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Champions Oncology (US) Humanized Mouse and Rat Model Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Horizon Discovery Group plc (UK)
2.14.1 Business Overview
2.14.2 Humanized Mouse and Rat Model Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Horizon Discovery Group plc (UK) Humanized Mouse and Rat Model Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Hera BioLabs (US)
2.15.1 Business Overview
2.15.2 Humanized Mouse and Rat Model Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Hera BioLabs (US) Humanized Mouse and Rat Model Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Yecuris Corporation (US)
2.16.1 Business Overview
2.16.2 Humanized Mouse and Rat Model Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Yecuris Corporation (US) Humanized Mouse and Rat Model Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Humanized Mouse and Rat Model Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Humanized Mouse and Rat Model Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Humanized Mouse and Rat Model Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Humanized Mouse and Rat Model Manufacturer Market Share in 2017
3.3.2 Top 6 Humanized Mouse and Rat Model Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Humanized Mouse and Rat Model Market Analysis by Regions
4.1 Global Humanized Mouse and Rat Model Sales, Revenue and Market Share by Regions
4.1.1 Global Humanized Mouse and Rat Model Sales and Market Share by Regions (2013-2018)
4.1.2 Global Humanized Mouse and Rat Model Revenue and Market Share by Regions (2013-2018)
4.2 North America Humanized Mouse and Rat Model Sales and Growth Rate (2013-2018)
4.3 Europe Humanized Mouse and Rat Model Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Humanized Mouse and Rat Model Sales and Growth Rate (2013-2018)
4.5 South America Humanized Mouse and Rat Model Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Humanized Mouse and Rat Model Sales and Growth Rate (2013-2018)
5 North America Humanized Mouse and Rat Model by Countries
5.1 North America Humanized Mouse and Rat Model Sales, Revenue and Market Share by Countries
5.1.1 North America Humanized Mouse and Rat Model Sales and Market Share by Countries (2013-2018)
5.1.2 North America Humanized Mouse and Rat Model Revenue and Market Share by Countries (2013-2018)
5.2 United States Humanized Mouse and Rat Model Sales and Growth Rate (2013-2018)
5.3 Canada Humanized Mouse and Rat Model Sales and Growth Rate (2013-2018)
5.4 Mexico Humanized Mouse and Rat Model Sales and Growth Rate (2013-2018)
6 Europe Humanized Mouse and Rat Model by Countries
6.1 Europe Humanized Mouse and Rat Model Sales, Revenue and Market Share by Countries
6.1.1 Europe Humanized Mouse and Rat Model Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Humanized Mouse and Rat Model Revenue and Market Share by Countries (2013-2018)
6.2 Germany Humanized Mouse and Rat Model Sales and Growth Rate (2013-2018)
6.3 UK Humanized Mouse and Rat Model Sales and Growth Rate (2013-2018)
6.4 France Humanized Mouse and Rat Model Sales and Growth Rate (2013-2018)
6.5 Russia Humanized Mouse and Rat Model Sales and Growth Rate (2013-2018)
6.6 Italy Humanized Mouse and Rat Model Sales and Growth Rate (2013-2018)
7 Asia-Pacific Humanized Mouse and Rat Model by Countries
7.1 Asia-Pacific Humanized Mouse and Rat Model Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Humanized Mouse and Rat Model Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Humanized Mouse and Rat Model Revenue and Market Share by Countries (2013-2018)
7.2 China Humanized Mouse and Rat Model Sales and Growth Rate (2013-2018)
7.3 Japan Humanized Mouse and Rat Model Sales and Growth Rate (2013-2018)
7.4 Korea Humanized Mouse and Rat Model Sales and Growth Rate (2013-2018)
7.5 India Humanized Mouse and Rat Model Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Humanized Mouse and Rat Model Sales and Growth Rate (2013-2018)
8 South America Humanized Mouse and Rat Model by Countries
8.1 South America Humanized Mouse and Rat Model Sales, Revenue and Market Share by Countries
8.1.1 South America Humanized Mouse and Rat Model Sales and Market Share by Countries (2013-2018)
8.1.2 South America Humanized Mouse and Rat Model Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Humanized Mouse and Rat Model Sales and Growth Rate (2013-2018)
8.3 Argentina Humanized Mouse and Rat Model Sales and Growth Rate (2013-2018)
8.4 Colombia Humanized Mouse and Rat Model Sales and Growth Rate (2013-2018)
9 Middle East and Africa Humanized Mouse and Rat Model by Countries
9.1 Middle East and Africa Humanized Mouse and Rat Model Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Humanized Mouse and Rat Model Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Humanized Mouse and Rat Model Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Humanized Mouse and Rat Model Sales and Growth Rate (2013-2018)
9.3 UAE Humanized Mouse and Rat Model Sales and Growth Rate (2013-2018)
9.4 Egypt Humanized Mouse and Rat Model Sales and Growth Rate (2013-2018)
9.5 Nigeria Humanized Mouse and Rat Model Sales and Growth Rate (2013-2018)
9.6 South Africa Humanized Mouse and Rat Model Sales and Growth Rate (2013-2018)
10 Global Humanized Mouse and Rat Model Market Segment by Type
10.1 Global Humanized Mouse and Rat Model Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Humanized Mouse and Rat Model Sales and Market Share by Type (2013-2018)
10.1.2 Global Humanized Mouse and Rat Model Revenue and Market Share by Type (2013-2018)
10.2 Genetic Sales Growth and Price
10.2.1 Global Genetic Sales Growth (2013-2018)
10.2.2 Global Genetic Price (2013-2018)
10.3 Cell-Based Sales Growth and Price
10.3.1 Global Cell-Based Sales Growth (2013-2018)
10.3.2 Global Cell-Based Price (2013-2018)
11 Global Humanized Mouse and Rat Model Market Segment by Application
11.1 Global Humanized Mouse and Rat Model Sales Market Share by Application (2013-2018)
11.2 Pharmaceutical Sales Growth (2013-2018)
11.3 Biotechnology Companies Sales Growth (2013-2018)
11.4 CRO Sales Growth (2013-2018)
12 Humanized Mouse and Rat Model Market Forecast (2018-2023)
12.1 Global Humanized Mouse and Rat Model Sales, Revenue and Growth Rate (2018-2023)
12.2 Humanized Mouse and Rat Model Market Forecast by Regions (2018-2023)
12.2.1 North America Humanized Mouse and Rat Model Market Forecast (2018-2023)
12.2.2 Europe Humanized Mouse and Rat Model Market Forecast (2018-2023)
12.2.3 Asia-Pacific Humanized Mouse and Rat Model Market Forecast (2018-2023)
12.2.4 South America Humanized Mouse and Rat Model Market Forecast (2018-2023)
12.2.5 Middle East and Africa Humanized Mouse and Rat Model Market Forecast (2018-2023)
12.3 Humanized Mouse and Rat Model Market Forecast by Type (2018-2023)
12.3.1 Global Humanized Mouse and Rat Model Sales Forecast by Type (2018-2023)
12.3.2 Global Humanized Mouse and Rat Model Market Share Forecast by Type (2018-2023)
12.4 Humanized Mouse and Rat Model Market Forecast by Application (2018-2023)
12.4.1 Global Humanized Mouse and Rat Model Sales Forecast by Application (2018-2023)
12.4.2 Global Humanized Mouse and Rat Model Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Humanized Mouse and Rat Model Picture
Table Product Specifications of Humanized Mouse and Rat Model
Figure Global Sales Market Share of Humanized Mouse and Rat Model
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
